AG
TGTX icon

AmeriFlex Group’s TG Therapeutics TGTX Stock Holding History

AmeriFlex Group’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.49K Hold
100
– – ﹤0.01% 1014
2026
Q1 		$3.32K Hold
100
– – ﹤0.01% 896
2025
Q4 		$2.98K Sell
100
-100
-50% -$3.27K ﹤0.01% 940
2025
Q3 		$7.22K Buy
200
+100
+100% +$3.29K ﹤0.01% 849
2025
Q2 		$3.79K Hold
100
– – ﹤0.01% 881
2025
Q1 		$3.94K Sell
100
-200
-67% -$6.73K ﹤0.01% 1038
2024
Q4 		$9.51K Buy
+300
New +$8.61K ﹤0.01% 785

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

AmeriFlex Group's TGTX Position: Q2 2026 in Review

AmeriFlex Group held its TG Therapeutics (TGTX) position steady in Q2 2026 at 100 shares worth $5.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1014.

AmeriFlex Group first reported a position in TGTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.51K in Q4 2024. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • AmeriFlex Group held 100 shares of TG Therapeutics worth $5.49K as of Q2 2026.
  • AmeriFlex Group left its TG Therapeutics share count unchanged in Q2 2026.
  • TG Therapeutics made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #1014 holding.
  • AmeriFlex Group first reported a position in TG Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's TG Therapeutics position peaked at $9.51K in Q4 2024.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.